![TSX Slouches Following Employment Numbers](https://i-invdn-com.investing.com/news/LYNXNPEB65083_S.jpg)
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1123 | 998 | 1123 | 630 | - | - |
Fund Return | 12.32% | -0.23% | 12.32% | -14.27% | - | - |
Place in category | 307 | 274 | 307 | 315 | - | - |
% in Category | 68 | 58 | 68 | 77 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPMorgan Global Income A Div EUR | 18.21B | 6.40 | -1.12 | 2.08 | ||
JPM Global Income Fund A Mth EUR | 18.21B | 6.39 | -1.14 | - | ||
JPMorgan Global Income D div EUR | 18.21B | 6.03 | -1.46 | 1.72 | ||
JPM Global Income A acc EUR | 18.21B | 6.40 | -1.12 | 2.08 | ||
LU0740858492 | 18.21B | 6.02 | -1.47 | 1.72 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1706168710 | 21.06B | 10.58 | -15.58 | - | ||
LU1255011097 | 21.06B | 11.42 | -14.94 | - | ||
LU1255011410 | 21.06B | 12.24 | -14.30 | - | ||
LU1997244873 | 2.67B | 14.62 | -16.70 | - | ||
Allianz China A Shares AT SGD | 2.67B | 14.82 | - | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Kweichow Moutai | CNE0000018R8 | 6.43 | 1,436.00 | +1.64% | |
Amperex Tech A | CNE100003662 | 6.03 | 261.28 | +3.23% | |
Ping An Insurance | CNE000001R84 | 4.65 | 50.88 | +1.25% | |
China Merchants Bank | CNE000001B33 | 4.29 | 40.20 | 0.00% | |
Midea Group A | CNE100001QQ5 | 3.60 | 73.44 | +1.62% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | BUY | Strong Buy |
Summary | Strong Buy | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review